Scan how Northrop Grumman’s latest PAC-3 order fits into a wider defense buildout by reviewing a curated list of munitions and defense primes in the 30 resilient stocks with low risk scores.
To own Northrop Grumman, you need to believe its mix of long cycle platforms, growing munitions work and national security space can keep turning a US$105b backlog into durable earnings, even with only moderate forecast growth. The analyst consensus Narrative on Simply Wall St leans on solid execution across B 21, Sentinel and missile programs as the key near term catalyst.
Right now, the biggest operational risk is cost or schedule missteps on complex fixed price contracts, especially while capital expenditure stays elevated around US$1.85b in 2026. The fresh PAC 3 order supports the munitions buildout, but does not remove the pressure to convert that higher capacity into profitable, on budget production.
The new quarterly dividend of US$2.47 per share underlines that Northrop Grumman continues to frame itself as a reliable cash return story alongside defense exposure. For you as a shareholder, that matters most if earnings and free cash flow can comfortably support both dividend payments and the heavier investment program.
Dividend affirmations also interact with catalysts around valuation and balance sheet risk. Analysts describe NOC as trading at a P/E below both peers and their fair value estimates, while also flagging a high level of debt. In that context, a maintained payout can be read as management signaling confidence in the underlying cash engine, but it also keeps the spotlight on execution and capital allocation discipline over the next few years.
Northrop Grumman’s outlook in analyst models rests on a mix of steady top line growth and only modest improvement in earnings, even as programs like PAC 3 scale. Forecasts point to revenue rising by 6.1% a year over the next three years, which sets an expectation that the enlarged munitions and solid rocket motor footprint will be used consistently rather than left under loaded.
On the profit side, the consensus view is more cautious. Analysts see net profit margins easing from 10.4% today to 9.1% in three years. That reflects the risk that cost pressure on fixed price contracts, heavier capital expenditure and the ramp of complex programs such as B 21 and Sentinel could offset some of the benefits from higher volume on missile work and other mature platforms.
Current earnings are put at US$4.5b, with analyst expectations pointing to US$4.8b of profit and earnings per share of US$34.03 by about 2029. That implies an earnings increase of roughly US$0.3b, which is a relatively small step up given the size of the backlog and the capital going into new capacity. For you as an investor, this framing underlines that execution on PAC 3 and other missile programs has to be both timely and disciplined to support even this measured lift in profitability.
Northrop Grumman's narrative projects revenues of US$52.1b and earnings of US$4.8b by 2029. This assumes yearly revenue growth of 6.1% and an earnings increase of about US$0.3b from US$4.5b today.
Analysts then use those 2029 numbers as anchors for how to think about valuation today. The consensus view assumes that, if revenues reach US$52.1b and earnings come in at US$4.8b, Northrop Grumman would be trading on a P/E of 23.8x, compared with 17.4x now and an industry multiple quoted at 31.3x. That set of assumptions is what underpins the current average price target of US$636 per share, which sits 13.1% above the latest share price reference of US$552.77.
There is still a wide range of opinion baked into those estimates. The most bullish analysts see fair value closer to US$815, while the most cautious are down at US$430. That spread tells you that views differ on how efficiently Northrop Grumman can convert its US$105b backlog, PAC 3 scale up and national security space work into earnings over the rest of this decade, and how much investors will be willing to pay for those earnings.
Uncover how Northrop Grumman's fair value indicates a 17% potential upside to its current price, which could narrow quickly if sentiment catches up.
One alternate view focuses on margin risk rather than PAC 3 growth. The most cautious Northrop Grumman analysts were modeling only about US$49.9b of revenue and US$4.2b of earnings by 2029, before this order or the latest dividend decision. That is a much more pessimistic story. Use it as a prompt to compare several angles yourself.
Explore another Northrop Grumman fair value estimate, including one that suggests it could be worth just $581.43.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so trust your own analysis.
If the Northrop Grumman story has sharpened your thinking on defense and cash generation, use that momentum to scan a wider field of opportunities with the Simply Wall St Screener. You can apply the same questions on balance sheet strength, income potential and valuation to a broader set of businesses and build a watchlist that fits your own risk and return preferences.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com